CamilleCournot

Associate

(T) 33.1.56.59.46.93

Connect:

Share

Camille Cournot's practice focuses on labor and employment issues involving union negotiations, employee representative bodies, and reorganizations and related litigation. She counsels French and international companies, particularly in the metals, energy, pharmaceutical, and emerging technologies industries, on all aspects of French labor and employment law. Camille also assists clients with labor audits, negotiations, and labor litigation before civil, criminal, and administrative courts.

Camille recently worked on several redundacy plans for companies in the metals industry.

Prior to joining Jones Day in 2014, Camille was an associate for three years at a French labor and employment firm.

Experience

  • Alizé Pharma 3 raises €67 million in financing roundJones Day represented Alizé Pharma 3 SAS, a French company engaged in the research and development of new therapeutic strategies for the treatment of rare endocrine and metabolic diseases, in connection with its €67 million (US$75 million) round of financing led by LSP, and included a syndicate of international investors.
  • Sentryo sold to CiscoJones Day represented Sentryo SAS and its shareholders in connection with the sale of Sentryo, a France-based provider of device visibility and security solutions for industrial control system (ICS) networks, to Cisco, a worldwide leader in IT, networking, and cybersecurity solutions.
  • PETRONAS Chemicals to acquire Da VinciJones Day is advising PETRONAS Chemicals Group Berhad (PCG) in its acquisition of a 100 percent stake in Da Vinci Group BV from its shareholders including funds managed by Bencis Capital Partner for €163 million (US$182.2 million).
  • Lincoln Electric acquires Air Liquide Welding for €115 million (US$134 million)Jones Day advised Lincoln Electric Holdings, Inc. in the €115 million (US$134 million) acquisition of the Air Liquide Welding subsidiary of Air Liquide, a key player in the manufacturing of welding and cutting technologies.
  • Euramax International sells Euramax Industries to Verdoso InvestmentsJones Day represented Euramax International, Inc. in connection with the sale of Euramax Industries SA, a manufacturer of motor vehicle parts and accessories, to Verdoso Investments SA.
  • Elaia Partners, Bpifrance, and Idinvest Partners invest in Stanley RoboticsJones Day advised Elaia Partners, Bpifrance (Ville de Demain), and Idinvest Partners in connection with the €3.6 million (US$4 million) financing round of Stanley Robotics, a developer of robotic valet parking services for all types of personal cars.
  • Wellington Partners, Bpifrance, CITA Investissement, CEA Investissement, and b-to-v Partners invest in UroMemsJones Day advised Wellington Partners, Bpifrance, CITA Investissement, CEA Investissement, and b-to-v Partners AG in connection with a €12 million ($12.7 million) private placement in UroMems, an innovative medtech company developing an active medical implantable device for treatment of urinary incontinence.
  • Pharnext completes €30.9 million IPO on Alternext market of Euronext in ParisJones Day represented Pharnext SAS, a biopharmaceutical company that develops new treatments targeting simultaneously several pathological mechanisms in neurological diseases, in connection with the €30.9 million (US$34.4 million) initial public offering on the Alternext market of Euronext in Paris.
  • New Alpha invests in UnilendJones Day advised New Alpha Asset Management in connection with its €2.5 million (US$2.8 million) equity investment in Unilend, a leading crowdlending platform for SMEs.
  • Criteo acquires Monsieur DriveJones Day advised Criteo S.A., a French technology company listed on the NASDAQ specializing in performance display advertising, in connection with its acquisition of Monsieur Drive, a French company which operates and develops digital advertising solutions for consumer brands.
  • Laboratoire HRA-Pharma sold to Astorg Partners and Goldman SachsJones Day advised Laboratoire HRA-Pharma SAS, a French pharmaceutical company, and its management in connection with its leveraged buy-out by Astorg Partners and Goldman Sachs.
  • NBS System sold to Oceanet TechnologyJones Day advised shareholders of No Blue Screen System (NBS System), a security software solution developer, in connection with its sale to Oceanet Technology, a provider of computer related services and consulting.
  • Databerries raises capital in Series A roundJones Day advised Databerries SAS, a France-based provider of mobile predictive marketing platform, in connection with its issuance of €1.7 million (US$1.86 million) of Series A Convertible Preferred Stock in a private placement to Isai and Mosaic Ventures.
  • Alven Capital invests in TinycluesJones Day represented Alven Capital SA in connection with its purchase of Series A Convertible Preferred Stock in a private placement by Tinyclues, a French publisher and seller of predictive CRM solutions.
  • Alven Capital invests in Thematic GroupeJones Day represented Alven Capital Partners SA in connection with its purchase of Series A Stock in a private placement by Thematic Groupe SAS d/b/a Wynd, a startup platform that digitalizes outlets and markets a modular software suite mainly to franchises catering.
  • Bpifrance Investissement managed fund invests in VULOGJones Day represented Bpifrance Investissement in connection with the investment by its managed fund Ecotechnologies in VULOG, a French SME and European leader in car sharing technology.
  • Xerys invests in ConnecthingsJones Day represented Xerys SA, as co-investor along with historical investors Siparex and Calao Finance, in connection with the purchase of €9.5 million (US$10.6 million) of Series B Preferred Shares in a private placement by Connecthings, a company focused on implementation of contactless mobile services.
  • 83North and Felix Capital invest in MiraklJones Day represented 83North and Felix Capital in connection with their purchase of $20 million of Series B Convertible Preferred Stock in a private placement by Mirakl, a global leader in e-commerce marketplace platforms.
  • Alven Capital and Bpifrance invest in GenymobileJones Day represented Alven Capital SA and Bpifrance in connection with their approximate $7 million equity investment in Genymobile SAS, an Android software publisher.
  • Alven Capital invests in VideoStitchJones Day represented Alven Capital SA in connection with its equity investment in VideoStitch SAS, a live VR video stitching software editor.
    • View All
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.